Unither Pharmaceuticals opens a Chinese subsidiary in Wuhan

unither

Unither Pharmaceutical Technologies (Wuhan) Co LTD main aim is to bring innovative technologies to Chinese pharmaceutical laboratories and patients. According to IMS Health the amelioration of access to healthcare implemented by the Chinese government should increase the drugs expenses and reach €170 billion in 2018.

Unither Pharmaceutical Technologies (Wuhan) Co LTD is located in Wuhan Optic Valley Biolake, this 30 Km2 park created in 2008 is mainly dedicated to health industries (biology, pharmaceutics et medical devices). Bio-Park is aiming to create a new city integrating R&D, incubation, manufacture, logistics and living. The Innovation science park now has gathered more than 700 enterprises and work sites such as Pfizer, Menarini, Bayer and Fresenius Kabi.

Our mission consists of creating local partnerships in order to help our customers from United States, Brazil and Europe entering the Chinese market.

Visit Unither’s booth